Donate

Nurse Education Webinar

Nursing Webinar 8- Oral Therapy

The topic for this webinar is oral therapies in Lymphoma/ CLL.

Oral therapies in Lymphoma is a growing area, with multiple drugs approved in the last 18 months and many more in the pipeline. Historically, patients on oral therapies receive less supportive contact with nurses and allied health professionals and at Lymphoma  Australia, we recognize this as an area for growth and expansion within clinician practice. 

Speakers for this event include, Neil Lam who is a Pharmacist of Advanced Oncology at Icon Cancer Centre Wesley. Neil will be discussing the different oral agents used in lymphoma, oral agents in the pipeline and some of the challenges with oral therapies. 

Oral Therapies
Presented by Neil Lam

Oncology Pharmacist – Clinical Lead
Icon Cancer Centre Wesley

Neil is the Cancer Pharmacist (Clinical Lead) at Icon Cancer Centre Wesley in Brisbane. Following his Pharmacy training, he completed a Master’s degree in Medical Science (Drug Development) and undertook certification in Geriatric Pharmacy (BCGP).

Over the past 20 years, he has worked in regulatory affairs, community pharmacy, sterile production and cancer services in the day hospital setting. His areas of interest include pharmaceutics and medication safety of cancer treatment. He is passionate about continuing professional education.

 

Support and information

Patient Online Forum

Find Out More

Lymphoma Nurse Support Phone Line: 1800 953 081
Free Resources for you

Find Out More

Lymphoma Nurse Support Email
nurse@lymphoma.org.au

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Share This
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.